Danske Bank’s ResMed RMD Stock Holding History

Danske Bank’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.8M	Sell	80,688 -7,653	-9%	-$1.67M	0.04%	341
2026 Q2	$17.2M	Sell	88,341 -19,401	-18%	-$4.02M	0.03%	348
2026 Q1	$24.2M	Buy	107,742 +606	+0.6%	+$151K	0.06%	263
2025 Q4	$25.8M	Sell	107,136 -54,410	-34%	-$13.9M	0.06%	261
2025 Q3	$44.2M	Sell	161,546 -27,266	-14%	-$7.45M	0.11%	157
2025 Q2	$48.7M	Buy	188,812 +85,306	+82%	+$20.3M	0.12%	147
2025 Q1	$23.2M	Sell	103,506 -36,620	-26%	-$8.55M	0.07%	226
2024 Q4	$32M	Sell	140,126 -54,475	-28%	-$13.1M	0.1%	187
2024 Q3	$47.5M	Buy	194,601 +24,221	+14%	+$5.41M	0.16%	122
2024 Q2	$32.6M	Sell	170,380 -21,485	-11%	-$4.36M	0.12%	153
2024 Q1	$38M	Buy	+191,865	New	+$35.2M	0.12%	160

Other funds holding RMD

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Danske Bank's RMD Position: Q3 2026 in Review

Danske Bank reduced its ResMed (RMD) stake by 8.7% in Q3 2026, selling an estimated $1.67M and leaving 80,688 shares worth $17.8M. The position accounts for 0.04% of the portfolio, ranked #341.

Danske Bank first reported a position in RMD in Q1 2024 and has held it in 11 quarters since. The position peaked at $48.7M in Q2 2025. 535 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

Danske Bank held 80,688 shares of ResMed worth $17.8M as of Q3 2026.
Danske Bank sold 7,653 ResMed shares in Q3 2026, an estimated $1.67M.
ResMed made up 0.04% of Danske Bank's portfolio in Q3 2026, its #341 holding.
Danske Bank first reported a position in ResMed in Q1 2024 and has held it in 11 quarters since.
Danske Bank's ResMed position peaked at $48.7M in Q2 2025.
535 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.